|
Fusion gene ID: 23873 |
FusionGeneSummary for NDUFB9_TDRKH |
Fusion gene summary |
Fusion gene information | Fusion gene name: NDUFB9_TDRKH | Fusion gene ID: 23873 | Hgene | Tgene | Gene symbol | NDUFB9 | TDRKH | Gene ID | 4715 | 11022 |
Gene name | NADH:ubiquinone oxidoreductase subunit B9 | tudor and KH domain containing | |
Synonyms | B22|CI-B22|LYRM3|UQOR22 | TDRD2 | |
Cytomap | 8q24.13 | 1q21.3 | |
Type of gene | protein-coding | protein-coding | |
Description | NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 9LYR motif-containing protein 3NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 9, 22kDaNADH-ubiquinone oxidoreductase B22 subunitcomplex I B22 subunit | tudor and KH domain-containing proteinputative RNA binding proteintudor domain containing 2tudor domain-containing protein 2 | |
Modification date | 20180523 | 20180519 | |
UniProtAcc | Q9Y6M9 | Q9Y2W6 | |
Ensembl transtripts involved in fusion gene | ENST00000522532, ENST00000276689, ENST00000518008, ENST00000517367, ENST00000517830, | ENST00000368827, ENST00000368825, ENST00000368824, ENST00000368823, ENST00000368822, ENST00000458431, ENST00000440583, ENST00000484421, | |
Fusion gene scores | * DoF score | 3 X 3 X 3=27 | 3 X 2 X 3=18 |
# samples | 4 | 4 | |
** MAII score | log2(4/27*10)=0.567040592723894 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | log2(4/18*10)=1.15200309344505 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | |
Context | PubMed: NDUFB9 [Title/Abstract] AND TDRKH [Title/Abstract] AND fusion [Title/Abstract] | ||
Functional or gene categories assigned by FusionGDB annotation |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
Partner | Gene | GO ID | GO term | PubMed ID |
Fusion gene information from three resources (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
TCGA | RV | BRCA | TCGA-AC-A6IX-01A | NDUFB9 | chr8 | 125551528 | + | TDRKH | chr1 | 151755525 | - |
TCGA | RV | BRCA | TCGA-AC-A6IX-06A | NDUFB9 | chr8 | 125551528 | + | TDRKH | chr1 | 151755525 | - |
* LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
5CDS-5UTR | ENST00000522532 | ENST00000368827 | NDUFB9 | chr8 | 125551528 | + | TDRKH | chr1 | 151755525 | - |
5CDS-5UTR | ENST00000522532 | ENST00000368825 | NDUFB9 | chr8 | 125551528 | + | TDRKH | chr1 | 151755525 | - |
5CDS-5UTR | ENST00000522532 | ENST00000368824 | NDUFB9 | chr8 | 125551528 | + | TDRKH | chr1 | 151755525 | - |
5CDS-5UTR | ENST00000522532 | ENST00000368823 | NDUFB9 | chr8 | 125551528 | + | TDRKH | chr1 | 151755525 | - |
5CDS-5UTR | ENST00000522532 | ENST00000368822 | NDUFB9 | chr8 | 125551528 | + | TDRKH | chr1 | 151755525 | - |
5CDS-5UTR | ENST00000522532 | ENST00000458431 | NDUFB9 | chr8 | 125551528 | + | TDRKH | chr1 | 151755525 | - |
5CDS-5UTR | ENST00000522532 | ENST00000440583 | NDUFB9 | chr8 | 125551528 | + | TDRKH | chr1 | 151755525 | - |
5CDS-5UTR | ENST00000522532 | ENST00000484421 | NDUFB9 | chr8 | 125551528 | + | TDRKH | chr1 | 151755525 | - |
5CDS-5UTR | ENST00000276689 | ENST00000368827 | NDUFB9 | chr8 | 125551528 | + | TDRKH | chr1 | 151755525 | - |
5CDS-5UTR | ENST00000276689 | ENST00000368825 | NDUFB9 | chr8 | 125551528 | + | TDRKH | chr1 | 151755525 | - |
5CDS-5UTR | ENST00000276689 | ENST00000368824 | NDUFB9 | chr8 | 125551528 | + | TDRKH | chr1 | 151755525 | - |
5CDS-5UTR | ENST00000276689 | ENST00000368823 | NDUFB9 | chr8 | 125551528 | + | TDRKH | chr1 | 151755525 | - |
5CDS-5UTR | ENST00000276689 | ENST00000368822 | NDUFB9 | chr8 | 125551528 | + | TDRKH | chr1 | 151755525 | - |
5CDS-5UTR | ENST00000276689 | ENST00000458431 | NDUFB9 | chr8 | 125551528 | + | TDRKH | chr1 | 151755525 | - |
5CDS-5UTR | ENST00000276689 | ENST00000440583 | NDUFB9 | chr8 | 125551528 | + | TDRKH | chr1 | 151755525 | - |
5CDS-5UTR | ENST00000276689 | ENST00000484421 | NDUFB9 | chr8 | 125551528 | + | TDRKH | chr1 | 151755525 | - |
5CDS-5UTR | ENST00000518008 | ENST00000368827 | NDUFB9 | chr8 | 125551528 | + | TDRKH | chr1 | 151755525 | - |
5CDS-5UTR | ENST00000518008 | ENST00000368825 | NDUFB9 | chr8 | 125551528 | + | TDRKH | chr1 | 151755525 | - |
5CDS-5UTR | ENST00000518008 | ENST00000368824 | NDUFB9 | chr8 | 125551528 | + | TDRKH | chr1 | 151755525 | - |
5CDS-5UTR | ENST00000518008 | ENST00000368823 | NDUFB9 | chr8 | 125551528 | + | TDRKH | chr1 | 151755525 | - |
5CDS-5UTR | ENST00000518008 | ENST00000368822 | NDUFB9 | chr8 | 125551528 | + | TDRKH | chr1 | 151755525 | - |
5CDS-5UTR | ENST00000518008 | ENST00000458431 | NDUFB9 | chr8 | 125551528 | + | TDRKH | chr1 | 151755525 | - |
5CDS-5UTR | ENST00000518008 | ENST00000440583 | NDUFB9 | chr8 | 125551528 | + | TDRKH | chr1 | 151755525 | - |
5CDS-5UTR | ENST00000518008 | ENST00000484421 | NDUFB9 | chr8 | 125551528 | + | TDRKH | chr1 | 151755525 | - |
5CDS-5UTR | ENST00000517367 | ENST00000368827 | NDUFB9 | chr8 | 125551528 | + | TDRKH | chr1 | 151755525 | - |
5CDS-5UTR | ENST00000517367 | ENST00000368825 | NDUFB9 | chr8 | 125551528 | + | TDRKH | chr1 | 151755525 | - |
5CDS-5UTR | ENST00000517367 | ENST00000368824 | NDUFB9 | chr8 | 125551528 | + | TDRKH | chr1 | 151755525 | - |
5CDS-5UTR | ENST00000517367 | ENST00000368823 | NDUFB9 | chr8 | 125551528 | + | TDRKH | chr1 | 151755525 | - |
5CDS-5UTR | ENST00000517367 | ENST00000368822 | NDUFB9 | chr8 | 125551528 | + | TDRKH | chr1 | 151755525 | - |
5CDS-5UTR | ENST00000517367 | ENST00000458431 | NDUFB9 | chr8 | 125551528 | + | TDRKH | chr1 | 151755525 | - |
5CDS-5UTR | ENST00000517367 | ENST00000440583 | NDUFB9 | chr8 | 125551528 | + | TDRKH | chr1 | 151755525 | - |
5CDS-5UTR | ENST00000517367 | ENST00000484421 | NDUFB9 | chr8 | 125551528 | + | TDRKH | chr1 | 151755525 | - |
intron-5UTR | ENST00000517830 | ENST00000368827 | NDUFB9 | chr8 | 125551528 | + | TDRKH | chr1 | 151755525 | - |
intron-5UTR | ENST00000517830 | ENST00000368825 | NDUFB9 | chr8 | 125551528 | + | TDRKH | chr1 | 151755525 | - |
intron-5UTR | ENST00000517830 | ENST00000368824 | NDUFB9 | chr8 | 125551528 | + | TDRKH | chr1 | 151755525 | - |
intron-5UTR | ENST00000517830 | ENST00000368823 | NDUFB9 | chr8 | 125551528 | + | TDRKH | chr1 | 151755525 | - |
intron-5UTR | ENST00000517830 | ENST00000368822 | NDUFB9 | chr8 | 125551528 | + | TDRKH | chr1 | 151755525 | - |
intron-5UTR | ENST00000517830 | ENST00000458431 | NDUFB9 | chr8 | 125551528 | + | TDRKH | chr1 | 151755525 | - |
intron-5UTR | ENST00000517830 | ENST00000440583 | NDUFB9 | chr8 | 125551528 | + | TDRKH | chr1 | 151755525 | - |
intron-5UTR | ENST00000517830 | ENST00000484421 | NDUFB9 | chr8 | 125551528 | + | TDRKH | chr1 | 151755525 | - |
Top |
FusionProtFeatures for NDUFB9_TDRKH |
Main function of each fusion partner protein. (from UniProt) |
Hgene | Tgene |
NDUFB9 | TDRKH |
Accessory subunit of the mitochondrial membranerespiratory chain NADH dehydrogenase (Complex I), that is believedto be not involved in catalysis. Complex I functions in thetransfer of electrons from NADH to the respiratory chain. Theimmediate electron acceptor for the enzyme is believed to beubiquinone. {ECO:0000269|PubMed:27626371}. | Participates in the primary piRNA biogenesis pathway andis required during spermatogenesis to repress transposableelements and prevent their mobilization, which is essential forthe germline integrity. The piRNA metabolic process mediates therepression of transposable elements during meiosis by formingcomplexes composed of piRNAs and Piwi proteins and govern themethylation and subsequent repression of transposons. Required forthe final steps of primary piRNA biogenesis by participating inthe processing of 31-37 nt intermediates into mature piRNAs. Mayact in pi-bodies and piP-bodies by transferring piRNA precursorsor intermediates to or between these granules.{ECO:0000250|UniProtKB:Q80VL1}. |
Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at . * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for NDUFB9_TDRKH |
For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. (nt: nucleotides, aa: amino acids) |
* Fusion amino acid sequences. |
* Fusion transcript sequences (only coding sequence (CDS) region). |
* Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for NDUFB9_TDRKH |
Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in . |
Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
NDUFB9 | MAGEA11, GDF9, FEZ1, IKBKAP, SH3GL3, HAP1, IMMT, RBBP6, NDUFA2, NDUFB5, NDUFS1, NDUFA12, NDUFB10, NDUFA5, ATP5B, ATP5O, ATP5F1, ATP5J2, ATP5C1, MPV17, ABCC1, ABCC2, LAMTOR3, MSLN, SYNE2, HSPA1L, STX4, ILF3, SDHB, MRPS28, MEF2A, XRN1, NXF1, NDUFS3, PRPS1, PRRT2, SPG7, ENPP6, NDUFA8, CLTC, LYRM5, NDUFA6, NDUFA9, NDUFB8, MTCH2, NDUFB7, POR, RAB1A, RPN1, VDAC2, NDUFS5, TIMMDC1, FBXW7, C15orf48, NDUFA4, NDUFB11, NDUFS6, RHPN1, KLHL22, NDUFS7, CSGALNACT2, FUT1, UBC, TRIM25 | TDRKH | RNF2, ARHGAP19 |
- Retained PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
- Lost PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
- Retained PPIs, but lost function due to frame-shift fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for NDUFB9_TDRKH |
Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.0 2018-04-02) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for NDUFB9_TDRKH |
Diseases associated with fusion partners. (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | NDUFB9 | C0043094 | Weight Gain | 1 | CTD_human |